Cargando…
The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan
The objective of this study is to determine the risk of tuberculosis (TB) disease in biologics users among rheumatoid arthritis (RA) patients in Taiwan from 2000 to 2015. This retrospective cohort study enrolled adult RA patients initiated on first biologics at Taichung Veterans General Hospital. TB...
Autores principales: | Lim, Chong Hong, Chen, Hsin-Hua, Chen, Yi-Hsing, Chen, Der-Yuan, Huang, Wen-Nan, Tsai, Jaw-Ji, Hsieh, Tsu-Yi, Hsieh, Chia-Wei, Hung, Wei-Ting, Lin, Ching-Tsai, Lai, Kuo-Lung, Tang, Kuo-Tung, Tseng, Chih-Wei, Chen, Yi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453436/ https://www.ncbi.nlm.nih.gov/pubmed/28570568 http://dx.doi.org/10.1371/journal.pone.0178035 |
Ejemplares similares
-
Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry
por: Lin, Ching-Tsai, et al.
Publicado: (2021) -
Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis
por: Lin, Ching-Tsai, et al.
Publicado: (2023) -
Herpes Zoster in rheumatoid arthritis patients receiving tofacitinib, a single center experience from Taiwan
por: Chen, Yen-Ju, et al.
Publicado: (2020) -
Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis
por: Chen, Yi-Ming, et al.
Publicado: (2017) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)